Pronavi Microcatheter – Paving the Way for CTO Lesions
Release time:
2022-10-08
BrosMed Medical sincerely invites you to attend our coming webinar “Pronavi Microcatheter – Paving the Way for CTO Lesions” on Tuesday Oct. 11st, 2022 at 08:30-10:00 (CEST) or 09:30-11:00 (TRT & EEST).
BrosMed Medical sincerely invites you to attend our coming webinar “Pronavi Microcatheter – Paving the Way for CTO Lesions” on Tuesday Oct. 11st, 2022 at 08:30-10:00 (CEST) or 09:30-11:00 (TRT & EEST).
With two kinds of tip design, Pronavi provides more choices for clininal uses. The balanced tip of Pronavi 1.7F with small tip entry profile 0.0225” achieves easy navigation in tortuous and complex anatomy; and the tapered tip of Pronavi 1.9F provides exceptional durability and pushability through tight calcified lesions in difficult to enter side branches.
It would be an academic feast as the experts will be on live to share their latest experiences and in-depth tips & tricks on clinical application of Pronavi microcatheters:
Dr. Raymundo Ocaranza-Sanchez. MD. PhD, Head of Interventional Cardiology Unit, Lucus Augusti University Hospital, Lugo.
Dr. José Antonio Fernández Díaz, Interventional Cardiologist at Hospital Universitario Puerta De Hierro Majadahonda, Madrid.
Dr. Yiannis (Ioannis) Tsiafoutis, Director in First Cardiology Department, Red Cross Hospital, Athens
Dr. Cuneyt KOCAS, Professor of Cardiology at Biruni University Hospital, Istanbul
If you are interested in attending the webinar, please scan the QR code on the poster or click the link to register and join with us and watch the live broadcast.
Join Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
BrosMed Announces Canadian Approval of RevoEdge™ High-Pressure Cutting Balloon
BrosMed Medical today announced Canadian regulatory approval of the RevoEdge™ High-Pressure Cutting Balloon Dilatation Catheter, expanding the company’s presence in North America and marking another milestone in the global commercialization of its specialty coronary portfolio.
2026-09-14
BrosMed Announced CE MDR Approval of VascuGlide™ Microcatheter System
June 15, 2026-BrosMed is pleased to announce that the VascuGlide™ Microcatheter System has received CE MDR certification, marking another significant milestone in the company's commitment to advancing peripheral intervention solutions.
2026-06-18
